If you need more lookups,
subscriptions start at $34 USD/month.
Roberto Gomez Location
Argentina
Roberto Gomez Work
2023 -now Medical Director @ Laboratorio Pablo Cassará
2020 -2023 TA Head Oncology Cluster South Latam (Argentina, Chile, Peru) @
2018 -2020 Director Medical Affairs Oncology Southern Cone (Argentina-Chile-Peru) @ Merck
2011 -2017 Director of Medical Affairs @
2005 -2011 Project Manager Oncology and Biotechnology @
2001 -2005 Respiratory Medical Marketing Manager @
1996 -2001 Medical Director @
1995 -1996 Medical Director @
1992 -1995 Product manager @ Lepetit
1990 -1992 Medical Advisor @ Lepetit
1987 -1989 Visiting Professor @ New York Medical Hospital
1981 -1987 Investigator of National Resaerch Council @ Instituto de Investigaciones cardiológicas
Roberto Gomez Education
University of Buenos Aires
Physician
1975-1980
Roberto Gomez Skills
Oncology
Clinical Trials
Clinical Development
Clinical Research
Pharmaceuticals
Clinical Trial Management
GCP
Life Sciences
Vaccines
Product Development
Research
Biotechnology
Pharmacovigilance
Infectious Diseases
Pharmaceutical Industry
Drug Development
Clinical Monitoring
Health Economics
ICH-GCP
Medicine
Sop
Medical Affairs
Regulatory Affairs
Clinical Trial Management System (CTMS)
CTMS
Market Access
Lifesciences
Therapeutic Areas
Medical Education
Good Clinical Practice (GCP)
Hospital Sales
CRO
FDA
Sales Effectiveness
Rheumatology
Clinical Trial Management System Ctms
Ich Gcp
Good Clinical Practice Gcp
Clinical Trial Management System
Good Clinical Practice
Roberto Gomez Summary
Roberto Gomez, based in Argentina, is currently a Medical Director at Laboratorio Pablo Cassará. Roberto Gomez brings experience from previous roles at MSD, Merck and Laboratorio ELEA. Roberto Gomez holds a 1975 - 1980 Physician @ University of Buenos Aires. With a robust skill set that includes Oncology, Clinical Trials, Clinical Development, Clinical Research, Pharmaceuticals and more. Roberto Gomez has 1 emails on RocketReach.
Looking for a different Roberto Gomez?
Find contact details for 700 million professionals.